Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Voglibose may help treat skin hyperpigmentation safely.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Hibiscus petals helped control blood sugar and improve liver and pancreas health in diabetic rats.

GLP-1RA medications may increase the risk of hair loss, especially in non-diabetic people.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to weight loss-related nutrient deficiency.

Empagliflozin helps heal diabetic wounds in rats by reducing inflammation and oxidative stress.

GLP-1 agonists may increase the risk of hair loss.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

The treatment cleared psoriasis in some patients but caused side effects in most.

GLP-1 medications can cause skin and muscle issues, but treatments like ultrasound and PRP can help.

GLP-1 receptor agonists increase the risk of hair loss, mainly due to nutrient deficiency from weight loss.

Incretin-based drugs for obesity often cause gastrointestinal issues, with tirzepatide having the most reports.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

GLP-1 receptor agonists may increase the risk of hair loss, especially non-scarring types, due to weight loss-related nutrient deficiencies.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Finasteride may worsen blood sugar control in diabetic patients.

Linagliptin slows down premature aging in certain mice.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.